Mitral Valve Regurgitation Quantification From 3D Color Doppler Ultrasound - Standard of Care Data Collection
Sponsor: Philips Electronics Nederland B.V. acting through Philips CTO organization
Listed as NCT03286088, this NA trial focuses on Mitral Valve Regurgitation of Any Grade and remains completed. Sponsored by Philips Electronics Nederland B.V. acting through Philips CTO organization, it has been updated 10 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Nov 2021 — Jul 2024 [monthly]
Completed NA
Status: Unknown Status → Completed
-
Oct 2021 — Nov 2021 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jan 2021 — Oct 2021 [monthly]
Recruiting NA
▶ Show 5 earlier versions
-
Mar 2020 — Jan 2021 [monthly]
Recruiting NA
-
Jun 2019 — Mar 2020 [monthly]
Recruiting NA
-
Aug 2018 — Jun 2019 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jun 2018 — Aug 2018 [monthly]
Not Yet Recruiting NA
-
Oct 2017 — Jun 2018 [monthly]
Not Yet Recruiting NA
First recorded
Aug 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Philips Electronics Nederland B.V. acting through Philips CTO organization
For direct contact, visit the study record on ClinicalTrials.gov .